A thyristor will stay conducting until the current through the device is zero (“current zero”) or perhaps slightly negative. LLNL’s approach is to use the opticondistor (“OTV”) to force this current zero in order to force the device into an “off” state. By combining a light-activated thyristor with an OTV, a noise-immune, high efficiency, high-power switching device can be constructed. The…
Keywords
- Show all (99)
- Instrumentation (38)
- Diagnostics (13)
- Electric Grid (8)
- Carbon Utilization (6)
- Therapeutics (5)
- Brain Computer Interface (BCI) (4)
- Materials for Energy Products (4)
- Synthesis and Processing (3)
- 3D Printing (2)
- Additive Manufacturing (2)
- Direct Air Capture (2)
- Rare Earth Elements (REEs) (2)
- Geologic Storage (1)
- Inertial Fusion Energy (IFE) (1)
- Membranes (1)
- Semiconductors (1)
- Simulation (1)
- Spectrometers (1)
- (-) Power Electronics (2)
- (-) Vaccines (2)
The approach is to leverage the fact that a momentary “load” equal to the power transmission line impedance, (Z0), during the transient can suppress its propagation. Z(0) is typically a fixed impedance of several hundred ohms based on the geometry of most single wire transmission lines.
So, an isolated self-powered opticondistor (OTV) system may provide an ultrafast method of…
LLNL’s novel approach is to use diamond substrates with the desired donor (nitrogen) and acceptor (boron) impurities. In order to optically activate these deep impurities, the invention requires at least one externally or internally integrated light source. The initial exposure to light can set up the desired conduction current, after which the light source could be turned off. Even with…
To replicate the physiology and functionality of tissues and organs, LLNL has developed an in vitro device that contains 3D MEAs made from flexible polymeric probes with multiple electrodes along the body of each probe. At the end of each probe body is a specially designed hinge that allows the probe to transition from lying flat to a more upright position when actuated and then…
LLNL’s high throughput method involves proteome-wide screening for linear B-cell epitopes using native proteomes isolated from a pathogen of interest and convalescent sera from immunized animals. LLNL researchers have applied their newly developed generalizable screening method to the identification of pathogenic bacteria by screening linear B-cell epitopes in the proteome of Francisella…
LLNL has developed a novel process of production, isolation, characterization, and functional re-constitution of membrane-associated proteins in a single step. In addition, LLNL has developed a colorimetric assay that indicates production, correct folding, and incorporation of bR into soluble nanolipoprotein particles (NLPs).
LLNL has developed an approach, for formation of NLP/…